Correction: High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation | Zendy

Open Access

Correction: High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation

Publication year - 2014

Publication title -

plos one

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.99

H-Index - 332

ISSN - 1932-6203

DOI - 10.1371/journal.pone.0110098

Subject(s) - idarubicin , cell growth , high throughput screening , computational biology , microbiology and biotechnology , pharmacology , chemistry , medicine , biology , bioinformatics , biochemistry , complete remission , chemotherapy

(UL1TR000427 to K.C.K.). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: ß 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research